Compare WVE & SXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | SXI |
|---|---|---|
| Founded | 2012 | 1955 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.7B |
| IPO Year | 2015 | 1994 |
| Metric | WVE | SXI |
|---|---|---|
| Price | $13.35 | $258.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 3 |
| Target Price | $31.47 | ★ $281.33 |
| AVG Volume (30 Days) | ★ 2.2M | 132.9K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.52% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.42 |
| Revenue | $3,704,000.00 | ★ $604,535,000.00 |
| Revenue This Year | N/A | $15.98 |
| Revenue Next Year | $119.93 | $8.09 |
| P/E Ratio | ★ N/A | $184.70 |
| Revenue Growth | ★ 149.43 | N/A |
| 52 Week Low | $5.28 | $128.85 |
| 52 Week High | $21.73 | $270.87 |
| Indicator | WVE | SXI |
|---|---|---|
| Relative Strength Index (RSI) | 47.54 | 53.19 |
| Support Level | $12.53 | $216.40 |
| Resistance Level | $14.56 | $266.94 |
| Average True Range (ATR) | 0.79 | 10.73 |
| MACD | 0.01 | -0.30 |
| Stochastic Oscillator | 23.84 | 64.91 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. The company has five reportable segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The maximum revenue is generated from its Electronics segment, which is a component and value-added services provider of both sensing and switching technologies, as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging, among others. Geographically, it derives key revenue from the United States and the rest from the Asia Pacific, Europe, the Middle East, and Africa (EMEA), as well as other regions.